表纸
市场调查报告书

动物用医药品的全球市场预测:2019-2028年

Global Veterinary Medicines Market Forecast 2019-2028

出版商 Inkwood Research 商品编码 962720
出版日期 内容资讯 英文 219 Pages
商品交期: 2-3个工作天内
价格
动物用医药品的全球市场预测:2019-2028年 Global Veterinary Medicines Market Forecast 2019-2028
出版日期: 2020年10月02日内容资讯: 英文 219 Pages
简介

全球动物用医药品的市场规模,从2019年到2028年的预测期间内,预计为4.53%的年复合成长率。家畜数的增加,医疗费的上升,宠物普及,及疾病盛行率增加,预计影响市场成长。

还有疫苗接种和疾病适时的诊断相关对动物健康的意识高涨,对全球动物用医药品的需求剧增有所贡献。同时,针对动物和人的健康的兽医用疫苗的副作用,基本的基础设施的缺乏,高额的疫苗接种,及严格的法规,妨碍市场成长。

本报告提供动物用医药品的全球市场调查,市场概要,影响市场的因素分析,各市场区隔、子区隔、地区的市场预测,并提供主要企业简介等资讯。

目录

第1章 调查范围、调查手法

  • 调查目的
  • 调查范围
  • 调查手法
  • 前提条件、限制事项

第2章 摘要整理

  • 市场规模、估计
  • 市场概要

第3章 市场动态

  • 市场定义
  • 主要的促进因素
    • 家畜数的剧增
    • 动物医疗费的上升
    • 所拥有的宠物增加
    • 动物的几个疾病盛行率的上升
  • 主要的阻碍因素
    • 有关动物用医药品的严格的法规
    • 对动物用疫苗相关的人及动物健康的副作用
    • 新兴经济各国的畜产基本基础设施设施的缺乏
    • 疫苗接种的高成本
    • 北美素食主义的人气高涨

第4章 主要分析

  • 波特的五力分析
  • 价值链分析
  • 法律规范
  • COVID-19对动物用医药品市场的影响
  • 机会矩阵
  • 业者情势
  • 主要的投资的考察

第5章 市场:各动物种类

  • 宠物
  • 家畜动物

第6章 市场:各流通管道

  • 零售动物医药局
  • 兽医医院的药局

第7章 市场:各给药途径

  • 非口服途径
  • 口服途径
  • 局部途径

第8章 市场:各产品

  • 药物
    • 抗感染疾病
    • 抗发炎药
    • 寄生虫驱除剂
  • 疫苗
    • 不活化疫苗
    • 弱毒化疫苗
    • 重组疫苗
  • 药用饲料添加物
    • 抗生素
    • 氨基酸

第9章 地区分析

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 俄罗斯
    • 波兰
    • 比利时
    • 其他欧洲
  • 亚太地区
    • 中国
    • 日本
    • 澳洲、纽西兰
    • 印度
    • 韩国
    • 泰国
    • 印尼
    • 越南
    • 其他亚太地区
  • 其他地区
    • 南美
    • 中东、非洲

第10章 企业简介

  • ARCHER DANIELS MIDLAND
  • BIOGENESIS BAGO SA
  • BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH
  • CEVA SANTE ANIMALE
  • DECHRA PHARMACEUTICALS PLC
  • ELANCO
  • EVONIK INDUSTRIES AG (RAG STIFTUNG)
  • HESTER BIOSCIENCES LIMITED
  • INDIAN IMMUNOLOGICALS LIMITED
  • KINDRED BIOSCIENCES
  • MERCK & CO
  • NEOGEN CORPORATION
  • VETOQUINOL (SOPARFIN SCA)
  • VIRBAC SA
  • ZOETIS
目录
Product Code: 34133

KEY FINDINGS

The global veterinary medicines market is estimated to grow with a CAGR of 4.53% during the forecast period, 2019-2028. The increasing livestock population, rising healthcare expenditure, growing pet ownership, and rising prevalence of diseases, are projected to influence the growth of the market.

MARKET INSIGHTS

Animals undergo different medical conditions that require immediate treatment and attention. Vaccines, medicated feed additives, and drugs, used for such treatment are called veterinary medicines. These prevent or slow the growth of the fungi and bacteria. The company of animals is known to enhance the quality of life, and has a positive impact on human health. There has been a considerable rise in pet ownership across the globe. In 2018 alone, 1 in 80 million households owned a pet in Europe. Thus, such a huge population is fueling the demand for veterinary medicines. Also, the rising awareness of animal health with regard to vaccine regimes and timely diagnosis of diseases are contributing to the surge in demand for veterinary medicines across the world. At the same time, the side effects of veterinary vaccines on animal & human health, lack of basic infrastructure, costly vaccinations, and strict regulations, are set to hamper the market growth.

REGIONAL INSIGHTS

The geographical analysis of the global veterinary medicines market includes the evaluation of Asia Pacific, Europe, North America, and the rest of the world. North America is set to dominate the global market throughout the forecast period. The increasing number of pet owners is one of the dominant factors contributing to the growth of the region.

COMPETITIVE INSIGHTS

The global veterinary medicines market is evaluated to be highly competitive over the forecast period. Some of the major players in the market include, Archer Daniels Midland, Biogenesis Bago SA, Boehringer Ingelheim Animal Health GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. SURGING LIVESTOCK POPULATION
    • 3.2.2. INCREASING ANIMAL HEALTHCARE EXPENDITURE
    • 3.2.3. GROWING PET OWNERSHIP
    • 3.2.4. RISE IN THE PREVALENCE OF SEVERAL DISEASES IN ANIMALS
  • 3.3. KEY RESTRAINTS
    • 3.3.1. STRINGENT REGULATIONS WITH RESPECT TO THE VETERINARY MEDICINES
    • 3.3.2. SIDE EFFECTS ASSOCIATED WITH VETERINARY VACCINES ON HUMAN AND ANIMAL HEALTH
    • 3.3.3. LACK OF BASIC INFRASTRUCTURE FACILITIES FOR THE VETERINARY ANIMALS IN THE UNDERDEVELOPED ECONOMIES
    • 3.3.4. HIGH COST OF VACCINATIONS
    • 3.3.5. RISING POPULARITY OF VEGETARIANISM AND VEGANISM IN NORTH AMERICA

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCE ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. VALUE CHAIN ANALYSIS
  • 4.3. REGULATORY FRAMEWORK
  • 4.4. IMPACT OF COVID-19 ON VETERINARY MEDICINES MARKET
  • 4.5. OPPORTUNITY MATRIX
  • 4.6. VENDOR LANDSCAPE
  • 4.7. KEY INVESTMENT INSIGHTS

5. MARKET BY ANIMAL TYPE

  • 5.1. COMPANION ANIMALS
  • 5.2. LIVESTOCK ANIMALS

6. MARKET BY DISTRIBUTION CHANNEL

  • 6.1. RETAIL VETERINARY PHARMACIES
  • 6.2. VETERINARY HOSPITAL PHARMACIES

7. MARKET BY ROUTE OF ADMINISTRATION

  • 7.1. PARENTERAL ROUTE
  • 7.2. ORAL ROUTE
  • 7.3. TOPICAL ROUTE

8. MARKET BY PRODUCT

  • 8.1. DRUGS
    • 8.1.1. ANTI-INFECTIVE
    • 8.1.2. ANTI-INFLAMMATORY
    • 8.1.3. PARASITICIDE
  • 8.2. VACCINES
    • 8.2.1. INACTIVATED VACCINES
    • 8.2.2. ATTENUATED VACCINES
    • 8.2.3. RECOMBINANT VACCINES
  • 8.3. MEDICATED FEED ADDITIVES
    • 8.3.1. ANTIBIOTICS
    • 8.3.2. AMINO ACIDS

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. THE UNITED STATES
    • 9.1.2. CANADA
  • 9.2. EUROPE
    • 9.2.1. GERMANY
    • 9.2.2. FRANCE
    • 9.2.3. THE UNITED KINGDOM
    • 9.2.4. ITALY
    • 9.2.5. RUSSIA
    • 9.2.6. POLAND
    • 9.2.7. BELGIUM
    • 9.2.8. REST OF EUROPE
  • 9.3. ASIA PACIFIC
    • 9.3.1. CHINA
    • 9.3.2. JAPAN
    • 9.3.3. AUSTRALIA & NEW ZEALAND
    • 9.3.4. INDIA
    • 9.3.5. SOUTH KOREA
    • 9.3.6. THAILAND
    • 9.3.7. INDONESIA
    • 9.3.8. VIETNAM
    • 9.3.9. REST OF ASIA PACIFIC
  • 9.4. REST OF WORLD
    • 9.4.1. LATIN AMERICA
    • 9.4.2. MIDDLE EAST & AFRICA

10. COMPANY PROFILES

  • 10.1. ARCHER DANIELS MIDLAND
  • 10.2. BIOGENESIS BAGO SA
  • 10.3. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH
  • 10.4. CEVA SANTE ANIMALE
  • 10.5. DECHRA PHARMACEUTICALS PLC
  • 10.6. ELANCO
  • 10.7. EVONIK INDUSTRIES AG (RAG STIFTUNG)
  • 10.8. HESTER BIOSCIENCES LIMITED
  • 10.9. INDIAN IMMUNOLOGICALS LIMITED
  • 10.10. KINDRED BIOSCIENCES
  • 10.11. MERCK & CO
  • 10.12. NEOGEN CORPORATION
  • 10.13. VETOQUINOL (SOPARFIN SCA)
  • 10.14. VIRBAC SA
  • 10.15. ZOETIS

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - VETERINARY MEDICINES
  • TABLE 2: NUMBER OF HOUSEHOLDS IN THE UNITED STATES OWNING A PET (MILLION)
  • TABLE 3: GLOBAL VETERINARY MEDICINES MARKET, BY ANIMAL TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 4: GLOBAL VETERINARY MEDICINES MARKET, BY ANIMAL TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 5: GLOBAL COMPANION ANIMALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 6: GLOBAL COMPANION ANIMALS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 7: GLOBAL LIVESTOCK ANIMALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 8: GLOBAL LIVESTOCK ANIMALS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 9: GLOBAL VETERINARY MEDICINES MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 10: GLOBAL VETERINARY MEDICINES MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 11: GLOBAL RETAIL VETERINARY PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 12: GLOBAL RETAIL VETERINARY PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 13: GLOBAL VETERINARY HOSPITAL PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 14: GLOBAL VETERINARY HOSPITAL PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 15: GLOBAL VETERINARY MEDICINES MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 16: GLOBAL VETERINARY MEDICINES MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 17: GLOBAL PARENTERAL ROUTE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 18: GLOBAL PARENTERAL ROUTE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 19: GLOBAL ORAL ROUTE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 20: GLOBAL ORAL ROUTE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 21: GLOBAL TOPICAL ROUTE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 22: GLOBAL TOPICAL ROUTE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 23: GLOBAL VETERINARY MEDICINES MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 24: GLOBAL VETERINARY MEDICINES MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 25: GLOBAL DRUGS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 26: GLOBAL DRUGS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 27: GLOBAL DRUGS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 28: GLOBAL DRUGS MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 29: GLOBAL VACCINES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 30: GLOBAL VACCINES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 31: GLOBAL VACCINES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 32: GLOBAL VACCINES MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 33: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 34: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 35: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 36: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 37: GLOBAL VETERINARY MEDICINES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 38: GLOBAL VETERINARY MEDICINES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 39: NORTH AMERICA VETERINARY MEDICINES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 40: NORTH AMERICA VETERINARY MEDICINES MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 41: EUROPE VETERINARY MEDICINES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 42: EUROPE VETERINARY MEDICINES MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 43: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 44: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 45: REST OF WORLD VETERINARY MEDICINES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 46: REST OF WORLD VETERINARY MEDICINES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: LIVESTOCK SPECIES POPULATION IN INDIA, 2019, (MILLION)
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: IMPACT OF COVID-19 ON VETERINARY MEDICINES MARKET
  • FIGURE 4: OPPORTUNITY MATRIX
  • FIGURE 5: VENDOR LANDSCAPE
  • FIGURE 6: GLOBAL VETERINARY MEDICINES MARKET, BY ANIMAL TYPE, IN 2019
  • FIGURE 7: GLOBAL VETERINARY MEDICINES MARKET, BY COMPANION ANIMALS, 2019-2028 (IN $ MILLION)
  • FIGURE 8: GLOBAL VETERINARY MEDICINES MARKET, BY LIVESTOCK ANIMALS, 2019-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL VETERINARY MEDICINES MARKET, BY DISTRIBUTION CHANNEL, IN 2019
  • FIGURE 10: GLOBAL VETERINARY MEDICINES MARKET, BY RETAIL VETERINARY PHARMACIES, 2019-2028 (IN $ MILLION)
  • FIGURE 11: GLOBAL VETERINARY MEDICINES MARKET, BY VETERINARY HOSPITAL PHARMACIES, 2019-2028 (IN $ MILLION)
  • FIGURE 12: GLOBAL VETERINARY MEDICINES MARKET, BY ROUTE OF ADMINISTRATION, IN 2019
  • FIGURE 13: GLOBAL VETERINARY MEDICINES MARKET, BY PARENTERAL ROUTE, 2019-2028 (IN $ MILLION)
  • FIGURE 14: GLOBAL VETERINARY MEDICINES MARKET, BY ORAL ROUTE, 2019-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL VETERINARY MEDICINES MARKET, BY TOPICAL ROUTE, 2019-2028 (IN $ MILLION)
  • FIGURE 16: GLOBAL VETERINARY MEDICINES MARKET, BY PRODUCT, IN 2019
  • FIGURE 17: GLOBAL VETERINARY MEDICINES MARKET, BY DRUGS, 2019-2028 (IN $ MILLION)
  • FIGURE 18: GLOBAL DRUGS MARKET, BY ANTI-INFECTIVE, 2019-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL DRUGS MARKET, BY ANTI-INFLAMMATORY, 2019-2028 (IN $ MILLION)
  • FIGURE 20: GLOBAL DRUGS MARKET, BY PARASITICIDE, 2019-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL VETERINARY MEDICINES MARKET, BY VACCINES, 2019-2028 (IN $ MILLION)
  • FIGURE 22: GLOBAL VACCINES MARKET, BY INACTIVATED VACCINES, 2019-2028 (IN $ MILLION)
  • FIGURE 23: GLOBAL VACCINES MARKET, BY ATTENUATED VACCINES, 2019-2028 (IN $ MILLION)
  • FIGURE 24: GLOBAL VACCINES MARKET, BY RECOMBINANT VACCINES, 2019-2028 (IN $ MILLION)
  • FIGURE 25: GLOBAL VETERINARY MEDICINES MARKET, BY MEDICATED FEED ADDITIVES, 2019-2028 (IN $ MILLION)
  • FIGURE 26: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY ANTIBIOTICS, 2019-2028 (IN $ MILLION)
  • FIGURE 27: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY AMINO ACIDS, 2019-2028 (IN $ MILLION)
  • FIGURE 28: NORTH AMERICA VETERINARY MEDICINES MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 29: THE UNITED STATES VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 30: CANADA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 31: EUROPE VETERINARY MEDICINES MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 32: GERMANY VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 33: FRANCE VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 34: THE UNITED KINGDOM VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 35: ITALY VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 36: RUSSIA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 37: POLAND VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 38: BELGIUM VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 39: REST OF EUROPE VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 40: ASIA PACIFIC VETERINARY MEDICINES MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 41: CHINA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 42: JAPAN VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 43: AUSTRALIA & NEW ZEALAND VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 44: INDIA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 45: SOUTH KOREA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 46: THAILAND VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 47: INDONESIA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 48: VIETNAM VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 49: REST OF ASIA PACIFIC VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 50: REST OF WORLD VETERINARY MEDICINES MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 51: LATIN AMERICA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 52: MIDDLE EAST & AFRICA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)